Walter E Aulitzky
Overview
Explore the profile of Walter E Aulitzky including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
869
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Silkenstedt E, Arenas F, Colom-Sanmarti B, Xargay-Torrent S, Higashi M, Giro A, et al.
J Exp Clin Cancer Res
. 2019 Nov;
38(1):446.
PMID: 31676012
Background: NOTCH1 gene mutations in mantle cell lymphoma (MCL) have been described in about 5-10% of cases and are associated with significantly shorter survival rates. The present study aimed to...
12.
von Tresckow B, Sayehli C, Aulitzky W, Goebeler M, Schwab M, Braz E, et al.
Eur J Haematol
. 2018 Oct;
102(2):163-173.
PMID: 30347469
Objectives: Domatinostat (4SC-202) is a selective class I histone deacetylase inhibitor (HDACi). This phase I study investigated safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and antitumor activity in patients with advanced hematological...
13.
Heine S, Kleih M, Gimenez N, Bopple K, Ott G, Colomer D, et al.
J Hematol Oncol
. 2018 Sep;
11(1):112.
PMID: 30180865
Background: Mantle cell lymphoma (MCL) is an aggressive B-non-Hodgkin lymphoma with generally poor outcome. MCL is characterized by an aberrantly high cyclin D1-driven CDK4 activity. New molecular targeted therapies such...
14.
Horing E, Staiger A, Lenze D, Horn H, Vohringer M, Steurer W, et al.
Leuk Lymphoma
. 2017 Jun;
59(1):249-252.
PMID: 28583033
No abstract available.
15.
Horing E, Montraveta A, Heine S, Kleih M, Schaaf L, Vohringer M, et al.
Br J Haematol
. 2017 Mar;
177(4):557-561.
PMID: 28295185
Imbalances in the composition of BCL2 family proteins contribute to tumourigenesis and therapy resistance of mantle cell lymphoma (MCL), making these proteins attractive therapy targets. We studied the efficiency of...
16.
Staiger A, Duppel J, Dengler M, van der Kuip H, Vohringer M, Aulitzky W, et al.
Leuk Lymphoma
. 2016 Dec;
58(8):1922-1930.
PMID: 27919179
Treatment response of follicular lymphomas (FL) is highly variable. We, therefore, investigated the role of FL cancer-associated fibroblasts (CAFs) on tumor cell viability, in particular in response to treatment with...
17.
Schaaf L, Schwab M, Ulmer C, Heine S, Murdter T, Schmid J, et al.
Cancer Res
. 2016 Mar;
76(10):2868-75.
PMID: 27013194
Although hyperthermia offers clinical appeal to sensitize cells to chemotherapy, this approach has been limited in terms of long-term outcome as well as economic and technical burden. Thus, a more...
18.
Schaaf L, van der Kuip H, Zopf W, Winter S, Munch M, Murdter T, et al.
Ann Surg Oncol
. 2015 Sep;
22 Suppl 3:S758-65.
PMID: 26350370
Background: Hyperthermic intraperitoneal chemotherapy (HIPEC) following cytoreductive surgery is a radical but effective treatment option for patients with peritoneal carcinomatosis (PC). Unfortunately, a standardized HIPEC protocol is missing impeding systematic...
19.
Rollig C, Bornhauser M, Kramer M, Thiede C, Ho A, Kramer A, et al.
J Clin Oncol
. 2014 Dec;
33(5):403-10.
PMID: 25547501
Purpose: The presence of a mutated nucleophosmin-1 gene (NPM1(mut)) in acute myeloid leukemia (AML) is associated with a favorable prognosis. To assess the predictive value with regard to allogeneic stem-cell...
20.
Gutekunst M, Mueller T, Weilbacher A, Dengler M, Bedke J, Kruck S, et al.
Cancer Res
. 2013 Jan;
73(5):1460-9.
PMID: 23302226
Testicular germ cell tumors (TGCT) are considered a paradigm of chemosensitive tumors. Embryonal carcinoma cells represent the pluripotent entity of TGCTs and are characterized by expression of Oct-4, a key...